CNS chloride modulation and uses thereof

Details for Australian Patent Application No. 2004238057 (hide)

Owner Universite Laval

Inventors De Koninck, Paul; Coull, Jeffrey A. M.; De Koninck, Yves

Agent Cullen & Co

Pub. Number AU-B-2004238057

PCT Pub. Number WO2004/101072

Priority 60/470,885 16.05.03 US

Filing date 14 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 24 September 2009

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/00 (2006.01)

A61K 49/00 (2006.01) Preparations for testing

A61P 23/00 (2006.01) Anaesthetics

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101072 Priority application(s): WO2004/101072

24 September 2009 Application Accepted

  Published as AU-B-2004238057

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238076-Injectable liposomal depots for delivering active ingredients

2004238053-Construction implement for granular bed regeneration